TrialDiabetes, obesity & metabolism2015
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial.
M A Abdul-Ghani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
83 papers cite itlatest 60 shown
this paperpooled ittrialcites it